Hipertrigliceridemia severa. Tratamiento con plasmaféresis

Nefrologia

Volumn 32, Issue 3, 2012, Pages 417-418

  Izquierdo Ortiz, M Jesús ^a   Abaigar Luquin, Pedro ^a  

^a HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLIC ACID RESIN; ANTILIPEMIC AGENT; FENOFIBRATE; FLUOROBENZENE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PYRIMIDINE DERIVATIVE; ROSUVASTATIN; SULFONAMIDE;

CASE REPORT; CHEMICAL PHENOMENA; FILTRATION; HUMAN; HYPERTRIGLYCERIDEMIA; INSTRUMENTATION; LETTER; MALE; METHODOLOGY; MIDDLE AGED; MOLECULAR WEIGHT; MULTIMODALITY CANCER THERAPY; PLASMAPHERESIS; PRACTICE GUIDELINE;

ACRYLIC RESINS; COMBINED MODALITY THERAPY; FENOFIBRATE; FILTRATION; FLUOROBENZENES; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTRIGLYCERIDEMIA; HYPOLIPIDEMIC AGENTS; MALE; MIDDLE AGED; MOLECULAR WEIGHT; PLASMAPHERESIS; PRACTICE GUIDELINES AS TOPIC; PYRIMIDINES; SULFONAMIDES;

EID: 84864508648     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2012.Feb.11394     Document Type: Letter

References (5)

1. Seidel D. H.E.L.P apheresis therapy in the treatment of severe hypercholesterolemia: 10 years of clinical experience. Artif Organs 1996;20:303-10.
2. Manrique Franco K, Sánchez-Vilar Burdiel O, Aragón Valera C, Sánchez Fernández MS, Rovira Loscos A. Plasmapheresis as treatment for severe hypertriglyceridemia. Endocrinol Nutr 2011;58(6):319-20.
3. Ewald N, Kloer HU. Severe hypertriglyceridemia: an indication for apheresis? Atheroscler Suppl 2009;10(5):49-52.
4. Syed H, Bilusic M, Rhondla C, Tavaria A. Plasmapheresis in the treatment of hypertriglyceridemia-induced pancreatitis: A community hospital's experience. J Clin Apher 2010;25(4):229-34.
5. Julius U, Tselmin S, Fischer S, Passauer J, Bornstein SR. The Dresden Apheresis Center - experience with LDL apheresis and immunoadsorption. Atheroscler Suppl 2009;10(5):12-6.